4-87811421-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004967.4(IBSP):āc.465G>Cā(p.Glu155Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,613,264 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IBSP | NM_004967.4 | c.465G>C | p.Glu155Asp | missense_variant | 7/7 | ENST00000226284.7 | NP_004958.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IBSP | ENST00000226284.7 | c.465G>C | p.Glu155Asp | missense_variant | 7/7 | 1 | NM_004967.4 | ENSP00000226284.5 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152062Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000180 AC: 45AN: 249926Hom.: 0 AF XY: 0.000215 AC XY: 29AN XY: 135110
GnomAD4 exome AF: 0.000131 AC: 192AN: 1461084Hom.: 0 Cov.: 38 AF XY: 0.000133 AC XY: 97AN XY: 726848
GnomAD4 genome AF: 0.000197 AC: 30AN: 152180Hom.: 1 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The c.465G>C (p.E155D) alteration is located in exon 7 (coding exon 6) of the IBSP gene. This alteration results from a G to C substitution at nucleotide position 465, causing the glutamic acid (E) at amino acid position 155 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at